Genus PLC
1 March 2002
FOR IMMEDIATE RELEASE 1 March 2002
Directors Share Transaction
In order to meet institutional demand, Richard Wood, CEO, and Philip Acton,
Finance Director, of Genus plc have today exercised options at 50p per share
over 145,000 ordinary shares of 10p each and 75,000 ordinary shares of 10p each
respectively.
The resultant shares have been sold at 150p per share.
Also, for the same reason today, Philip Acton has sold 30,000 existing ordinary
shares at 150p.
These transactions represent only 0.75% of the issued share capital in Genus
plc.
Following these transactions, the options remaining in favour of Richard Wood
and Philip Acton will amount to 539,437 ordinary shares and 292,276 ordinary
shares respectively. Philip Acton will also be the beneficial holder of 35,256
ordinary shares.
Contact:
For further information, please contact :
Genus Tel: +44 (0)1270 536 500
Richard Wood, Chief Executive
Philip Acton, Finance Director
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.